Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNDK
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Fulcrum Therapeutics
FULC
$291M
| $415K | ﹤0.01% |
113,319
+2,194
| +2% | +$13.3K |
|
3252
Neumora Therapeutics
NMRA
$235M
| $413K | ﹤0.01% |
243,195
+37,266
| +18% | +$70.9K |
|
3253
SIGA Technologies
SIGA
$230M
| $412K | ﹤0.01% |
113,091
+1,573
| +1% | +$7.04K |
|
3254
WisdomTree International MidCap Dividend Fund
DIM
$166M
| $412K | ﹤0.01% |
4,829
-335
| -6% | -$29K |
|
3255
Avalo Therapeutics
AVTX
$1.06B
| $411K | ﹤0.01% |
+22,226
| New | +$351K |
|
3256
Organogenesis Holdings
ORGO
$206M
| $410K | ﹤0.01% |
168,904
+6,167
| +4% | +$15.1K |
|
3257
Larimar Therapeutics
LRMR
$424M
| $410K | ﹤0.01% |
134,483
+114,836
| +584% | +$456K |
|
3258
Everspin Technologies
MRAM
$405M
| $408K | ﹤0.01% |
+16,867
| New | +$378K |
|
3259
Vista Energy
VIST
$8.39B
| $408K | ﹤0.01% |
6,391
+927
| +17% | +$65.3K |
|
3260
Nuveen Multi-Asset Income Fund
NMAI
$488M
| $408K | ﹤0.01% |
28,773
+499
| +2% | +$6.86K |
|
|
ABVX
3261
Abivax
ABVX
$10.4B
| $408K | ﹤0.01% |
3,058
-123,362
| -98% | -$14M |
|
|
JBIO
3262
Jade Biosciences
JBIO
$1.24B
| $403K | ﹤0.01% |
18,119
-11,441
| -39% | -$239K |
|
|
HDSN
3263
Hudson Technologies
HDSN
$225M
| $402K | ﹤0.01% |
70,075
-8,711
| -11% | -$49.6K |
|
3264
TORM
TRMD
$3.58B
| $400K | ﹤0.01% |
15,365
-1,576
| -9% | -$47.7K |
|
3265
OmniAb
OABI
$616M
| $397K | ﹤0.01% |
161,376
+26,289
| +19% | +$52.2K |
|
3266
Invivyd
IVVD
$243M
| $397K | ﹤0.01% |
454,530
+74,118
| +19% | +$92.9K |
|
3267
Inogen
INGN
$139M
| $396K | ﹤0.01% |
61,388
+5,281
| +9% | +$34.9K |
|
|
ARX
3268
Accelerant Holdings
ARX
$4.31B
| $395K | ﹤0.01% |
+33,735
| New | +$474K |
|
3269
Bel Fuse Inc Class A
BELFA
$2.97B
| $395K | ﹤0.01% |
+1,355
| New | +$329K |
|
3270
Richardson Electronics
RELL
$262M
| $394K | ﹤0.01% |
20,750
+1,703
| +9% | +$26.6K |
|
3271
Beyond Meat
BYND
$193M
| $394K | ﹤0.01% |
17,506
-12,089
| -41% | -$282K |
|
|
JCAP
3272
Jefferson Capital
JCAP
$1.24B
| $393K | ﹤0.01% |
+20,195
| New | +$377K |
|
3273
Quantum-Si Incorporated
QSI
$166M
| $393K | ﹤0.01% |
443,929
+37,239
| +9% | +$35.5K |
|
3274
iShares MSCI EAFE ETF
EFA
$79.7B
| $392K | ﹤0.01% |
3,778
-7,311
| -66% | -$752K |
|
3275
RCI Hospitality Holdings
RICK
$222M
| $391K | ﹤0.01% |
14,307
-1,386
| -9% | -$35.1K |
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.